Sources | Names Used |
---|---|
CTRPv2 | BRD-K04800985 |
PharmacoGx | BRD-K04800985 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EPS8L1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | SOCS1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | TGFB3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
mRNA | PLPPR1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
mRNA | C19orf57 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
mRNA | RUBCNL | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
mRNA | MAT1A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
mRNA | SPESP1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
mRNA | LINGO3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | SPAST | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |